SCHEMBL7607181

SCHEMBL7607181

COn1c(C(=O)O)c(-c2ccccc2)c2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.43
EDNRA P25101 2/20 0.42
MAPK8 P45983 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.41
LMNA P02545 2/20 0.41
KDM4E B2RXH2 3/20 0.40
AGTR1 P30556 2/20 0.40
RCE1 Q9Y256 1/20 0.40
EDNRB P24530 1/20 0.40
POLB P06746 2/20 0.40
TACR1 P25103 2/20 0.39
ALDH1A1 P00352 3/20 0.39
HPGD P15428 2/20 0.39
HTT P42858 1/20 0.39
PADI4 Q9UM07 1/20 0.39
MEN1 O00255 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
ACLY P53396 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1421429 0.79 CCR2 (0.51) KMT2AEDNRASMN1; SMN2LMNAKDM4E
SCHEMBL7593404 0.79 KMT2A (0.55) KMT2ASMN1; SMN2LMNAKDM4EPOLB
SCHEMBL28665614 0.77 MEN1 (0.44) KMT2ASMN1; SMN2KDM4EPOLBALDH1A1
SCHEMBL4399199 0.76 KMT2A (0.48) KMT2AEDNRASMN1; SMN2LMNAKDM4E
SCHEMBL7134859 0.76 KMT2A (0.44) KMT2AEDNRASMN1; SMN2LMNAKDM4E
SCHEMBL11791604 0.76 KMT2A (0.62) KMT2AEDNRASMN1; SMN2LMNAKDM4E
SCHEMBL27673202 0.75 MCL1 (0.48) KMT2AKDM4EPOLBALDH1A1HPGD
SCHEMBL4712636 0.73 MAPK8 (0.53) MAPK8TACR1ACLY
SCHEMBL6857637 0.72 EDNRA (0.53) KMT2AEDNRAKDM4EEDNRBALDH1A1
SCHEMBL16144912 0.70 LMNA (0.53) KMT2ASMN1; SMN2LMNAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165517-A1 N-BENZIMIDAZOLYLMETHYL- AND N-INDOLYLMETHYL-BENZAMIDES AND THEIR USE AS CRF MODULATORS NEUROGEN CORPORATION (US) 2002-01-02 EP disclosed
US-6281237-B1 MODULATORS OF CRF RECEPTORS AND ARE THEREFORE USEFUL FOR TREATING AFFECTIVE DISORDERS, ANXIETY, DEPRESSION, EATING DISORDERS, AND STRESS DISORDERS NEUROGEN CORPORATION 2001-08-28 US disclosed
WO-2000059888-A1 N-BENZIMIDAZOLYLMETHYL- AND N-INDOLYLMETHYL-BENZAMIDES AND THEIR USE AS CRF MODULATORS NEUROGEN CORPORATION (US) 2000-10-12 WO disclosed